Seguir
Athyros V
Athyros V
Emeritus Professor of Internal Medicine Aristotelian University, Thessaloniki, Greece
Dirección de correo verificada de med.auth.gr
Título
Citado por
Citado por
Año
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and …
VG Athyros, K Tziomalos, TD Gossios, T Griva, P Anagnostis, K Kargiotis, ...
The Lancet 376 (9756), 1916-1922, 2010
8702010
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus' usual'care in secondary coronary heart disease prevention
VG Athyros, AA Papageorgiou, BR Mercouris, VV Athyrou, ...
Current medical research and opinion 18 (4), 220-228, 2002
8192002
The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis
P Anagnostis, VG Athyros, K Tziomalos, A Karagiannis, DP Mikhailidis
The Journal of Clinical Endocrinology & Metabolism 94 (8), 2692-2701, 2009
8002009
Statin intolerance–an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical …
M Banach, M Rizzo, PP Toth, M Farnier, MH Davidson, K Al-Rasadi, ...
Expert opinion on drug safety 14 (6), 935-955, 2015
5592015
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart …
VG Athyros, DP Mikhailidis, AA Papageorgiou, AN Symeonidis, ...
Journal of clinical pathology 57 (7), 728-734, 2004
5112004
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ...
Nutrition reviews 75 (5), 307-326, 2017
4202017
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
SG Tsouli, EN Liberopoulos, DP Mikhailidis, VG Athyros, MS Elisaf
Metabolism 55 (10), 1293-1301, 2006
3802006
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary …
VG Athyros, M Elisaf, AA Papageorgiou, AN Symeonidis, AN Pehlivanidis, ...
American journal of kidney diseases 43 (4), 589-599, 2004
371*2004
Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia
VG Athyros, AA Papageorgiou, VV Athyrou, DS Demitriadis, ...
Diabetes care 25 (7), 1198-1202, 2002
3442002
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
VG Athyros, DP Mikhailidis, TP Didangelos, OI Giouleme, ...
Current medical research and opinion 22 (5), 873-883, 2006
3332006
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ...
Current vascular pharmacology 9 (5), 533-571, 2011
3242011
Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis
VG Athyros, OI Giouleme, NL Nikolaidis, TV Vasiliadis, VI Bouloukos, ...
Journal of clinical gastroenterology 34 (4), 472-475, 2002
3092002
Diabetic nephropathy: new risk factors and improvements in diagnosis
K Tziomalos, VG Athyros
The review of diabetic studies: RDS 12 (1-2), 110, 2015
2882015
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a …
VG Athyros, DP Mikhailidis, EN Liberopoulos, AI Kakafika, A Karagiannis, ...
Nephrology Dialysis Transplantation 22 (1), 118-127, 2007
2862007
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related …
VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ...
Metabolism 71, 17-32, 2017
2812017
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
VG Athyros, ES Ganotakis, M Elisaf, DP Mikhailidis
Current medical research and opinion 21 (8), 1157-1159, 2005
2662005
Diabetes and lipid metabolism
VG Athyros, M Doumas, KP Imprialos, K Stavropoulos, E Georgianou, ...
Hormones 17, 61-67, 2018
2612018
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
2422019
The prevalence of the metabolic syndrome in Greece: the MetS‐Greece Multicentre Study
VG Athyros, VI Bouloukos, AN Pehlivanidis, AA Papageorgiou, ...
Diabetes, Obesity and Metabolism 7 (4), 397-405, 2005
2382005
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
HJ Milionis, AI Kakafika, SG Tsouli, VG Athyros, ET Bairaktari, ...
American heart journal 148 (4), 635-640, 2004
2372004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20